Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

Presentation TCT 2016

Comprehensive CT Algorithm Before TAVR

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, João L Cavalcante

November 01, 2016

Presentation TCT 2016

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval)

Presenter: Neil E. Moat, John G. Webb, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

Pragmatic Simple Trials and Big Data: Advantages and Caveats

Presenter: Deepak L. Bhatt, Roxana Mehran, Robert A. Harrington

October 31, 2016

Presentation TCT 2016

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

Presenter: Sorin J. Brener, Jean-François Tanguay, Rafael Cavalcante

October 31, 2016

Presentation TCT 2016

Caval Flow Regulator Catheter Balloon for Heart Failure Treatment

Presenter: Daniel Burkhoff, Ileana L. Pina, Jose E. Herrera

October 30, 2016

Presentation TVT 2016

Caval Valves for Tricuspid Regurgitation

Presenter: Alexander Lauten

June 17, 2016

Presentation SOLACI 2016

Left-Main Disease: When is PCI the Preferred Strategy?

Presenter: Rafael Cavalcante

June 08, 2016

Presentation SOLACI 2016

Is digital angiography (QCA) still a useful tool in the clinical practice?

Presenter: Ricardo Cavalcante e Silva

June 08, 2016

Presentation

Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism (PE)

Presenter: Behnood Bikdeli

February 28, 2016

Presentation TCT 2015

Percutaneous Transluminal Caval Flow Restriction With Counterpulsation Balloon in Ischemic and Nonischemic Heart Failure Patients

Presenter: Andrea Abizaid, Daniel Burkhoff, Jose E. Herrera

October 14, 2015

Presentation CICT 2015

Trans-caval TAVR

Presenter: Samir Kapadia

July 31, 2015

Presentation TVT 2015

Caval Sapien Valve Implants for Tricuspid Regurgitation

Presenter: Francesco Maisano, John G. Webb, Michael E Laule

June 05, 2015

Presentation

Vorapaxar in Patients with Diabetes and Prior MI:Findings from the TRA 2ºP-TIMI 50 Trial

Presenter: M.A. Cavender

February 19, 2015

Presentation TCT 2014

TCT 428: First Percutaneous Transluminal Caval Flow Restriction in a Patient with Congestive Heart Failure

Presenter: John C Criscione, Elmir Omerovic, Jose Herrera

September 16, 2014

Presentation TCT 2014

First Percutaneous Transluminal Caval flow Restriction in a Patient with Congestive Heart Failure_

Presenter: Jose Herrera

September 16, 2014

Presentation TCT 2014

Hurdles That Must Be Overcome in Designing and Implanting a Transcatheter Mitral Valve: Caveat Emptor! Insights from a Cardiac Surgeon

Presenter: Craig R. Smith, Alec S. Vahanian, Olaf Wendler, Neil E. Moat

September 14, 2014

Presentation

Bivalirudin vs Heparin in Patients Planned for PCI

Presenter: Matthew A. Cavender

August 20, 2014

Presentation TVT 2014

A Surgeons Perspective on TMVR: What are the Caveats?

Presenter: Michael J. Mack

June 06, 2014

Presentation ISET 2014

Chronic Iliac and Caval Revascularization Procedures: Who, How and Outcomes

Presenter: Parag J. Patel

January 17, 2014

Presentation

Caval-Aortic Access for TAVR

Presenter: Adam B. Greenbaum

December 01, 2013

Advertisement

Comprehensive CT Algorithm Before TAVR

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval)

Pragmatic Simple Trials and Big Data: Advantages and Caveats

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

Caval Flow Regulator Catheter Balloon for Heart Failure Treatment

Caval Valves for Tricuspid Regurgitation

Left-Main Disease: When is PCI the Preferred Strategy?

Is digital angiography (QCA) still a useful tool in the clinical practice?

Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism (PE)

Percutaneous Transluminal Caval Flow Restriction With Counterpulsation Balloon in Ischemic and Nonischemic Heart Failure Patients

Trans-caval TAVR

Caval Sapien Valve Implants for Tricuspid Regurgitation

Vorapaxar in Patients with Diabetes and Prior MI:Findings from the TRA 2ºP-TIMI 50 Trial

TCT 428: First Percutaneous Transluminal Caval Flow Restriction in a Patient with Congestive Heart Failure

First Percutaneous Transluminal Caval flow Restriction in a Patient with Congestive Heart Failure_

Hurdles That Must Be Overcome in Designing and Implanting a Transcatheter Mitral Valve: Caveat Emptor! Insights from a Cardiac Surgeon

Bivalirudin vs Heparin in Patients Planned for PCI

A Surgeons Perspective on TMVR: What are the Caveats?

Chronic Iliac and Caval Revascularization Procedures: Who, How and Outcomes

Caval-Aortic Access for TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content